Authors,Author(s) ID,Title,Year,Source tittle,Cited by,DOI,Country,Document Type,City,Access Type,aggregationType,EID
Oyama K.,,A COX-2 inhibitor prevents the esophageal inflammation-metaplasia- adenocarcinoma sequence in rats,2005,Carcinogenesis,73,10.1093/carcin/bgh340,Japan,Article,Kanazawa,1,Journal,2-s2.0-16244374632
Cook N.,,Low-dose aspirin in the primary prevention of cancer. The women's health study: A randomized controlled trial,2005,Journal of the American Medical Association,628,10.1001/jama.294.1.47,United States;United States,Article,Boston;Boston,1,Journal,2-s2.0-21444450527
Sharma P.,,Are screening and surveillance for Barrett's oesophagus really worthwhile?,2005,Gut,60,10.1136/gut.2004.041566,United States;United States,Conference Paper,Kansas City;,1,Journal,2-s2.0-14344258581
Lindblad M.,,Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer,2005,Cancer Epidemiology Biomarkers and Prevention,50,10.1158/1055-9965.EPI-04-0467,Sweden,Article,Stockholm,1,Journal,2-s2.0-13944274874
Hur C.,,Analysis of aspirin-associated risks in healthy individuals,2005,Annals of Pharmacotherapy,5,10.1345/aph.1E115,United States;United States,Article,Boston;Boston,0,Journal,2-s2.0-11144247022
Peek R.,,Prevention of colorectal cancer through the use of COX-2 selective inhibitors,2004,Cancer Chemotherapy and Pharmacology,41,10.1007/s00280-004-0887-x,United States,Conference Paper,Nashville,0,Journal,2-s2.0-8744284312
Jankowski J.,,Re: Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus (multiple letters) [2],2004,Journal of the National Cancer Institute,44,10.1093/jnci/djh171,United Kingdom;United Kingdom,Letter,Leicester;Leicester,1,Journal,2-s2.0-3042637088
Kubo A.,,Marked Multi-Ethnic Variation of Esophageal and Gastric Cardia Carcinomas within the United States,2004,American Journal of Gastroenterology,131,10.1111/j.1572-0241.2004.04131.x,,Article,,0,Journal,2-s2.0-2342555652
Hur C.,,Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus,2004,Journal of the National Cancer Institute,51,10.1093/jnci/djh039,United States,Article,Boston,1,Journal,2-s2.0-1342333710
Chan A.,,A Prospective Study of Aspirin Use and the Risk for Colorectal Adenoma,2004,Annals of Internal Medicine,148,10.7326/0003-4819-140-3-200402030-00006,United States,Article,Boston,0,Journal,2-s2.0-0742283971
González-Pérez A.,,Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: A metal-analysis,2003,BMC Cancer,147,10.1186/1471-2407-3-28,United States;Spain,Review,Boston;Madrid,1,Journal,2-s2.0-3042711948
Engel L.,,Population attributable risks of esophageal and gastric cancers,2003,Journal of the National Cancer Institute,499,10.1093/jnci/djg047,United States;United States,Article,Bethesda;New York,0,Journal,2-s2.0-0141506127
Dolan K.,,Loss of heterozygosity on chromosome 17p predicts neoplastic progression in Barrett's esophagus,2003,Journal of Gastroenterology and Hepatology (Australia),22,10.1046/j.1440-1746.2003.03048.x,United Kingdom;United Kingdom;Australia,Article,Liverpool;Liverpool;Perth,0,Journal,2-s2.0-0037713249
Tangrea J.,,Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States),2003,Cancer Causes and Control,58,10.1023/A:1024990617158,United States,Article,Bethesda,0,Journal,2-s2.0-0041488657
Rudolph R.E.,,Serum selenium levels in relation to markers of neoplastic progression among persons with Barrett's esophagus,2003,Journal of the National Cancer Institute,48,10.1093/jnci/95.10.750,United States,Article,Seattle,1,Journal,2-s2.0-0038278821
Polednak A.,,"Trends in survival for both histologic types of esophageal cancer in U.S. Surveillance, Epidemiology and End Results areas",2003,International Journal of Cancer,129,10.1002/ijc.11029,United States,Article,Hartford,0,Journal,2-s2.0-0037457655
Bosetti C.,,Aspirin use and cancers of the upper aerodigestive tract,2003,British Journal of Cancer,52,10.1038/sj.bjc.6600820,Italy,Article,Milan,1,Journal,2-s2.0-0037430063
Sandler R.,,A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer,2003,New England Journal of Medicine,947,10.1056/NEJMoa021633,United States,Article,Chapel Hill,0,Journal,2-s2.0-0037421984
Baron J.A.,,A randomized trial of aspirin to prevent colorectal adenomas,2003,New England Journal of Medicine,1168,10.1056/NEJMoa021735,United States;United States;United States,Article,Hanover;Lebanon;Lebanon,0,Journal,2-s2.0-0037421985
Thun M.,,NSAIDS and esophageal cancer: Ready for trials but not yet broad clinical application,2003,Gastroenterology,14,10.1053/gast.2003.50025,United States,Article,Atlanta,0,Journal,2-s2.0-0037221790
Corley D.,,Protective association of aspirin/NSAIDs and esophageal cancer: A systematic review and meta-analysis,2003,Gastroenterology,433,10.1053/gast.2003.50008,United States,Article,San Francisco,0,Journal,2-s2.0-0037219463
Kubo A.,,Marked regional variation in adenocarcinomas of the esophagus and the gastric cardia in the United States,2002,Cancer,109,10.1002/cncr.10940,United States;United States,Article,New York;Berkeley,0,Journal,2-s2.0-0037110660
Vaughan T.,,"Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett's esophagus",2002,Cancer Epidemiology Biomarkers and Prevention,85,,United States,Article,Seattle,0,Journal,2-s2.0-0036323531
Vizcaino A.,,"Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995",2002,International Journal of Cancer,347,10.1002/ijc.10427,France;France,Article,Lyon;Lyon,0,Journal,2-s2.0-0037142177
Husain S.,,NSAID inhibition of GI cancer growth: Clinical implications and molecular mechanisms of action,2002,American Journal of Gastroenterology,108,10.1016/S0002-9270(01)04090-4,United States,Review,Irvine,0,Journal,2-s2.0-0036130051
Buttar N.S.,,Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus,2002,Gastroenterology,326,10.1053/gast.2002.32371,United States,Article,Rochester,0,Journal,2-s2.0-0036204834
Rabinovitch P.,,Predictors of progression in Barrett's esophagus III: Baseline flow cytometric variables,2001,American Journal of Gastroenterology,223,10.1016/S0002-9270(01)03823-0,United States,Article,Seattle,0,Journal,2-s2.0-0035180041
Reid B.,,Predictors of progression in Barrett's esophagus II: Baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression,2001,American Journal of Gastroenterology,305,10.1016/S0002-9270(01)02798-8,United States;United States,Article,Seattle;Seattle,0,Journal,2-s2.0-0034793846
Bollschweiler E.,,Demographic variations in the rising incidence of esophageal adenocarcinoma in white males,2001,Cancer,385,10.1002/1097-0142(20010801)92:3<549::AID-CNCR1354>3.0.CO;2-L,Germany,Article,Koln,1,Journal,2-s2.0-0035423905
Morris C.,,Cyclooxygenase-2 expression in the barrett's metaplasia-dysplasia-adenocarcinoma sequence,2001,American Journal of Gastroenterology,233,10.1016/S0002-9270(00)02392-3,,Article,,0,Journal,2-s2.0-0035045145
Shirvani V.N.,,Cyclooxygenase 2 expression in barrett’s esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure,2001,Digestive Diseases and Sciences,86,10.1023/A:1010700400960,United States;United States,Article,Palo Alto;Palo Alto,0,Journal,2-s2.0-0035036921
Reid B.,,Predictors of progression to cancer in Barrett's esophagus: Baseline histology and flow cytometry identify low- and high-risk patient subsets,2000,American Journal of Gastroenterology,570,10.1016/S0002-9270(00)00988-6,United States;United States,Article,Seattle;Seattle,0,Journal,2-s2.0-0033915683
Weston A.,,"Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma",1999,American Journal of Gastroenterology,174,10.1016/S0002-9270(99)00661-9,United States;United States,Article,;Kansas City,0,Journal,2-s2.0-0032778599
Barry O'Connor J.,,The incidence of adenocarcinoma and dysplasia in Barrett's esophagus report on the Cleveland Clinic Barrett's esophagus registry,1999,American Journal of Gastroenterology,343,10.1016/S0002-9270(99)00331-7,United States,Article,Cleveland,0,Journal,2-s2.0-0033180027
Provenzale D.,,Barrett's esophagus: A new look at surveillance based on emerging estimates of cancer risk,1999,American Journal of Gastroenterology,322,10.1111/j.1572-0241.1999.01276.x,United States,Article,Durham,0,Journal,2-s2.0-0033180014
Morales T.,,"Barrett's esophagus: Update on screening, surveillance, and treatment",1999,Archives of Internal Medicine,52,10.1001/archinte.159.13.1411,United States;United States,Review,Tucson;Wheat Ridge,1,Journal,2-s2.0-0033549612
Teodori L.,,DNA/protein flow cytometry as a predictive marker of malignancy in dysplasia-free Barren's esophagus. Thirteen-year follow-up study on a cohort of patients,1998,Communications in Clinical Cytometry,78,10.1002/(SICI)1097-0320(19981215)34:6<257::AID-CYTO3>3.0.CO;2-S,Italy,Article,Rome,1,Journal,2-s2.0-0010005673
Vaughan T.,,"Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux",1998,Cancer Epidemiology Biomarkers and Prevention,90,,United States;United States;United States,Article,Seattle;Seattle;Seattle,0,Journal,2-s2.0-7344243229
Wilson K.,,Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas,1998,Cancer Research,543,,United States;United States,Article,Baltimore;Baltimore,0,Journal,2-s2.0-0032528178
Sampliner R.,,"Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus",1998,American Journal of Gastroenterology,614,10.1111/j.1572-0241.1998.00362.x,United States;United States,Review,Tucson;Tucson,0,Journal,2-s2.0-0032467590
Stürmer T.,,Aspirin use and colorectal cancer: Post-trial follow-up data from the Physicians' Health Study,1998,Annals of Internal Medicine,260,10.7326/0003-4819-128-9-199805010-00003,Germany,Article,Ulm,0,Journal,2-s2.0-2442493541
Farrow D.,,Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer,1998,Cancer Epidemiology Biomarkers and Prevention,422,,United States,Article,Seattle,0,Journal,2-s2.0-6844240876
Drewitz D.,,The incidence of adenocarcinoma in Barrett's esophagus: A prospective study of 170 patients followed 4.8 years,1997,American Journal of Gastroenterology,478,,United States,Article,Tucson,0,Journal,2-s2.0-0031039244
Van Der Burgh A.,,Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus,1996,Gut,291,10.1136/gut.39.1.5,Netherlands,Article,Rotterdam,1,Journal,2-s2.0-0029980994
Reid B.J.,,Flow-cytometric and histological progression to malignancy in Barrett's esophagus: Prospective endoscopic surveillance of a cohort,1992,Gastroenterology,411,10.1016/0016-5085(92)70015-4,United States,Article,Seattle,0,Journal,2-s2.0-0026518795
Phillips R.,,"Barrett's esophagus: Natural history, incidence, etiology, and complications",1991,Gastroenterology Clinics of North America,121,,United States,Review,Bethesda MD,0,Journal,2-s2.0-0026064785
Miros M.,,Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus,1991,Gut,272,10.1136/gut.32.12.1441,Australia,Article,Woolloongabba,1,Journal,2-s2.0-0025791931
Ovaska J.,,Adenocarcinoma arising in Barrett's esophagus,1989,Digestive Diseases and Sciences,99,10.1007/BF01538065,Finland,Article,Helsinki,0,Journal,2-s2.0-0024450023
Hameeteman W.,,Barrett's Esophagus; Development of Dysplasia and Adenocarcinoma,1989,Gastroenterology,823,10.1016/S0016-5085(89)80011-3,Netherlands,Article,Amsterdam,0,Journal,2-s2.0-0024505079
Robertson C.S.,,Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus,1988,British Journal of Surgery,260,10.1002/bjs.1800750813,United Kingdom,Article,Nottingham,0,Journal,2-s2.0-0023686651
Cameron A.,,The Incidence of Adenocarcinoma in Columnar-Lined (Barrett's) Esophagus,1985,New England Journal of Medicine,669,10.1056/NEJM198510033131404,United States,Article,Rochester,0,Journal,2-s2.0-0022253063
Spechler S.J.,,Adenocarcinoma and Barrett's esophagus. An overrated risk?,1984,Gastroenterology,440,10.1016/0016-5085(84)90090-8,United States;United States;United States,Article,Boston;Boston;Boston,1,Journal,2-s2.0-0021221863
